Latest Breaking News On - Dyne therapeutics inc - Page 1 : comparemela.com

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesStacy nartkerAmy reillyOxana beskrovnayaExchange commissionSociety international research congressDyne therapeutics incFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Dyne Therapeutics Presents New Preclinical Data for its

Dyne Therapeutics Presents New Preclinical Data for its
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAmy reillyStacy nartkerOxana beskrovnayaExchange commissionSociety international research congressDyne therapeutics incFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAmy reillyOxana beskrovnayaStacy nartkerFacioscapulohumeral muscular dystrophy program duringExchange commissionSociety international research congressDyne therapeutics incTherapeutics presents new preclinical dataInternational researchFunctional benefitInternational research congressScientific publicationsFacioscapulohumeral muscular dystrophyPrivate securities litigation reform act

Frazier Life Sciences Management L P Invests $15 76 Million in Dyne Therapeutics, Inc (NASDAQ:DYN)

Frazier Life Sciences Management L.P. bought a new position in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,184,840 shares of the company’s stock, valued at approximately $15,758,000. Frazier Life Sciences Management L.P. owned 1.93% of Dyne Therapeutics at […]

United statesOxana beskrovnayaStifel nicolausDyne therapeutics incChina universal asset management coMorgan stanleySg americas securitiesFrazier life sciences managementJefferies financial groupCorton capital incPrincipal financial group incProfund advisorsDyne therapeuticsFree reportUniversal asset managementFinancial group

Dyne Therapeutics, Inc (NASDAQ:DYN) COO Sells $2,419,200 00 in Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) COO Susanna Gatti High sold 80,000 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $30.24, for a total value of $2,419,200.00. Following the completion of the transaction, the chief operating officer now owns 154,062 […]

United statesPiper sandlerStifel nicolausDyne therapeutics incRussell investments group ltdPrincipal financial group incWetzel investment advisors incAmeritas investment partners incMirae asset global investments coSecurities exchange commissionDyne therapeuticsGet free reportGatti highExchange commissionSusanna gatti highTherapeutics stock down